Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients

被引：0
|
作者：
Ennio Lubrano
Fabio Massimo Perrotta
Silvia Scriffignano
Laura C. Coates
Philip Helliwell
机构：
[1] Università degli Studi del Molise,Dipartimento di Medicina e Scienze, della Salute “Vincenzo Tiberio”
[2] University of Oxford,Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
[3] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
Psoriatic arthritis; Remission; Very low disease activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：521 / 528
页数：7
相关论文
共 50 条
  • [11] Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
    Coates, Laura C.
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen J.
    Nantel, Francois
    RHEUMATOLOGY, 2019, 58 (03) : 522 - 526
  • [12] POST-EFFORT SYNOVIAL AND ENTHESIC RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS IN REMISSION OF LOW DISEASE ACTIVITY
    Guillen-Astete, C.
    Zurita-Prada, P.
    Urrego-Laurin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 761 - 761
  • [13] ACHIEVEMENT OF VERY LOW DISEASE ACTIVITY AND REMISSION TREATMENT TARGETS IS ASSOCIATED WITH REDUCED RADIOGRAPHIC PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
    Coates, L. C.
    Merola, J. F.
    Kavanaugh, A.
    Mease, P. J.
    Davies, O.
    Irvin-Sellers, O.
    Nurminen, T.
    Van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 754 - 755
  • [14] Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
    Coates, Laura C.
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen J.
    Nantel, Francois
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [15] Achievement of Very Low Disease Activity and Remission Treatment Targets Is Associated with Reduced Radiographic Progression in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol
    Coates, Laura
    Merola, Joseph
    Kavanaugh, Arthur
    Mease, Philip
    Davies, Owen
    Irvin-Sellers, Oscar
    Nurminen, Tommi
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [16] Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis (vol 46, pg 710, 2019)
    Queiro, R.
    Canete, J. D.
    Montilla, C.
    Abad, M. A.
    Montoro, M.
    Gomez, S.
    Cabez, A.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) : 1252 - 1252
  • [17] DAPSA REMISSION/LOW DISEASE ACTIVITY IS ASSOCIATED WITH LOW PSAID12 IN PSORIATIC ARTHRITIS
    Garcia-Porrua, C.
    Fernandez-Dominguez, L.
    Guerra-Vazquez, J. L.
    Mosquera Martinez, J. A.
    Pinto-Tasende, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1679 - 1680
  • [18] APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS
    Bessette, Louis
    Keystone, Edward
    Rahman, Proton
    Anderson, Keltie
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 27 - 27
  • [19] APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS
    Bessette, Louis
    Keystone, Ed
    Rahman, Proton
    Anderson, Keltie
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 9 - 9
  • [20] Application of Treat to Target and Impact of Sustained Low Disease Activity or Remission on Function in Rheumatoid Arthritis Patients
    Bessette, Louis
    Keystone, Edward
    Rahman, Proton
    Anderson, Keltie
    Rampakakis, Emmanouil
    Lehman, Allen
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1105 - 1106
12345